Yu A W, Shao L E, Frigon N L, Yu J
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.
Ann N Y Acad Sci. 1994 Apr 15;718:285-98; discussion 298-9. doi: 10.1111/j.1749-6632.1994.tb55727.x.
Activin A, which was initially recognized as a gonadal protein, was implicated in the modulation of erythropoiesis through a paracrine control in the bone marrow microenvironment. Present studies demonstrate that, in contrast to T lymphocytes and cultured skin fibroblasts, human marrow stromal cells produce a functional and dimeric beta A beta A molecule (i.e., activin A). RT-PCR further indicates that both alpha and beta A mRNAs of inhibin A/activin A are produced in human stromal cells. The level of beta A subunit mRNAs, however, is in large excess over that of alpha subunit mRNAs, suggesting the predominant production of beta A beta A dimers, as well as some inhibin A (alpha beta A). It should be noted, however, that the beta A subunit can form dimeric proteins other than activin A, such as activin AB (beta A beta B) and inhibin A (alpha beta A). Hence, the presence of the beta A subunit may not necessarily indicate the production of the activin A molecule in any tissue. Therefore, a special quantitative sandwich ELISA assay specific for the dimeric beta A beta A molecule was developed for the measurement of activin A. With this assay, production of activin A in marrow stromal cells is found to be greatly enhanced by cytokines and inflammatory mediators such as TNF-alpha, IL-1 alpha, and lipopolysaccharide. These studies thus suggest that inflammatory cytokines are the inducers for activin A, probably serving a role of up-regulating activin A production locally in bone marrow microenvironment. At present, activin A is not known to play any role in inflammatory reaction; this study may thus raise the possibility that activin A performs more functions than are currently recognized. Alternatively, the enhanced production of this molecule in the bone marrow microenvironment may be regarded as a compensatory mechanism in host defenses, countering inflammatory mediators that are known to suppress erythropoiesis.
激活素A最初被认为是一种性腺蛋白,通过骨髓微环境中的旁分泌控制参与红细胞生成的调节。目前的研究表明,与T淋巴细胞和培养的皮肤成纤维细胞不同,人骨髓基质细胞可产生一种功能性二聚体βAβA分子(即激活素A)。逆转录聚合酶链反应(RT-PCR)进一步表明,抑制素A/激活素A的α和βA信使核糖核酸(mRNA)在人基质细胞中均有产生。然而,βA亚基mRNA的水平大大超过α亚基mRNA的水平,这表明主要产生的是βAβA二聚体,以及一些抑制素A(αβA)。然而,应该注意的是,βA亚基除了能形成激活素A外,还能形成其他二聚体蛋白,如激活素AB(βAβB)和抑制素A(αβA)。因此,βA亚基的存在不一定表明任何组织中都产生了激活素A分子。因此,开发了一种针对二聚体βAβA分子的特殊定量夹心酶联免疫吸附测定(ELISA)法来检测激活素A。通过这种测定法,发现细胞因子和炎症介质如肿瘤坏死因子-α(TNF-α)、白细胞介素-1α(IL-1α)和脂多糖可大大增强骨髓基质细胞中激活素A的产生。这些研究因此表明,炎症细胞因子是激活素A的诱导剂,可能在骨髓微环境中局部上调激活素A的产生中发挥作用。目前,尚不清楚激活素A在炎症反应中起任何作用;因此,本研究可能提出激活素A具有比目前所认识到的更多功能的可能性。或者,这种分子在骨髓微环境中产生的增加可被视为宿主防御中的一种补偿机制,以对抗已知会抑制红细胞生成的炎症介质。